SUSMED,Inc. (TYO:4263)

Japan flag Japan · Delayed Price · Currency is JPY
962.00
-76.00 (-7.32%)
Feb 13, 2026, 2:44 PM JST
Market Cap17.45B +65.0%
Revenue (ttm)475.00M +38.9%
Net Income-255.00M
EPS-15.17
Shares Out16.81M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume170,900
Average Volume148,090
Open1,033.00
Previous Close1,038.00
Day's Range960.00 - 1,033.00
52-Week Range413.00 - 1,050.00
Beta1.31
RSI56.15
Earnings DateFeb 13, 2026

About SUSMED,Inc.

SUSMED,Inc. develops and sells therapeutic applications in Japan. It operates through DTx product business, and DTx platform business segments. The company develops smartphone based digital therapeutics applications for diseases with insomnia, breast cancer, and kidney disease. It also develops and sells development platform for therapeutic apps and clinical trial systems. In addition, the company offers medical data analysis and consulting services. The company was incorporated in 2015 and is headquartered in Tokyo, Japan. [Read more]

Industry Medical - Healthcare Information Services
Sector Healthcare
Founded 2015
Employees 43
Stock Exchange Tokyo Stock Exchange
Ticker Symbol 4263
Full Company Profile

Financial Performance

In fiscal year 2025, SUSMED,Inc.'s revenue was 462.00 million, an increase of 35.09% compared to the previous year's 342.00 million. Losses were -298.00 million, -16.53% less than in 2024.

Financial Statements